Products
Preparation registered in Ukraine
V. Subbotin
Ñomplex correction of platelet aggregation activity as the prevention of critical ischemia progression in patients with diabetic foot
Summary. The article deals with the investigation of the possibility of correction the platelet aggregation activity abnormalities in patients with diabetes as prevention of critical ischemia in the setting of steno-occlusive arterial disease of lower extremities with the help of complex therapy using «Ðlestazol» and non-medical correction. It has been established that the investigated treatment complex normalizes platelet aggregation activity in the given patients’ category for 4 months, and also significantly reduces the severity of ischemia in diabetic angiopathy of lower extremities. The results achieved were maintained for 6 months after the treatment.
Keywords: vessel wall, diabetes mellitus, «Ðlestazol», critical ischemia.